157 related articles for article (PubMed ID: 7206588)
1. [The pharmacokinetics of adriamycin and adriamycin-metabolites (author's transl)].
Ehninger G; Stocker HJ; Proksch B; Wilms K
Klin Wochenschr; 1980 Sep; 58(18):927-34. PubMed ID: 7206588
[TBL] [Abstract][Full Text] [Related]
2. Quantitative determination of adriamycin in rat hepatocytes using a volatile extraction buffer, HPLC and fluorescence detection.
Mahdadi R; Pommery N; Pommery J; Lhermitte M
Biomed Chromatogr; 1987; 2(3):91-4. PubMed ID: 3507221
[TBL] [Abstract][Full Text] [Related]
3. Marked inter-patient variation in adriamycin biotransformation to 7-deoxyaglycones: evidence from metabolites identified in serum.
Cummings J; Milstead R; Cunningham D; Kaye S
Eur J Cancer Clin Oncol; 1986 Aug; 22(8):991-1001. PubMed ID: 3770056
[TBL] [Abstract][Full Text] [Related]
4. Plasma pharmacokinetics of adriamycin and its metabolites in humans with normal hepatic and renal function.
Benjamin RS; Riggs CE; Bachur NR
Cancer Res; 1977 May; 37(5):1416-20. PubMed ID: 856462
[TBL] [Abstract][Full Text] [Related]
5. Bilary disposition of adriamycin.
Riggs CE; Benjamin RS; Serpick AA; Bachur NR
Clin Pharmacol Ther; 1977 Aug; 22(2):234-41. PubMed ID: 884924
[TBL] [Abstract][Full Text] [Related]
6. Pharmacokinetics and disposition of 4'-O-tetrahydropyranyladriamycin in mice by HPLC analysis.
Iguchi H; Tone H; Ishikura T; Takeuchi T; Umezawa H
Cancer Chemother Pharmacol; 1985; 15(2):132-40. PubMed ID: 4017162
[TBL] [Abstract][Full Text] [Related]
7. Determination of adriamycin and its fluorescent metabolites in human plasma by HPLC.
Mahdadi R; Lhermitte M; Lafitte JJ
Biomed Chromatogr; 1987 Feb; 2(1):38-40. PubMed ID: 3508093
[TBL] [Abstract][Full Text] [Related]
8. Mathematical model for adriamycin (doxorubicin) pharmacokinetics.
Reich SD; Steinberg F; Bachur NR; Riggs CE; Goebel R; Berman M
Cancer Chemother Pharmacol; 1979; 3(2):125-31. PubMed ID: 509697
[TBL] [Abstract][Full Text] [Related]
9. Rapid analytic method for adriamycin and metabolites in human plasma by a thin-film fluorescence scanner.
Watson E; Chan KK
Cancer Treat Rep; 1976 Nov; 60(11):1611-8. PubMed ID: 1035506
[TBL] [Abstract][Full Text] [Related]
10. New data on the pharmacokinetics of adriamycin and its major metabolite, adriamycinol.
Leca F; Marchiset-Leca D; Noble A; Antonetti M
Eur J Drug Metab Pharmacokinet; 1991; 16(2):107-11. PubMed ID: 1936069
[TBL] [Abstract][Full Text] [Related]
11. Plasma pharmacokinetics of adriamycin and adriamycinol: implications for the design of in vitro experiments and treatment protocols.
Greene RF; Collins JM; Jenkins JF; Speyer JL; Myers CE
Cancer Res; 1983 Jul; 43(7):3417-21. PubMed ID: 6850648
[TBL] [Abstract][Full Text] [Related]
12. Pharmacokinetic analysis of adriamycin (doxorubicin) and related fluorescent compounds in Ehrlich tumor-bearing mouse plasma and tissues.
Shinozawa S; Fukuda T; Araki Y; Oda T
Acta Med Okayama; 1982 Apr; 36(2):125-32. PubMed ID: 7136849
[TBL] [Abstract][Full Text] [Related]
13. Quantitative thin-layer chromatography: thin-film fluorescence scanning analysis of adriamycin and metabolites in tissue.
Chan KK; Wong CD
J Chromatogr; 1979 Apr; 172():343-9. PubMed ID: 548536
[TBL] [Abstract][Full Text] [Related]
14. Pharmacokinetics of adriamycin and adriamycinol after intravenous administration of adriamycin to rats with water-deprivation for 48 hours.
Lee HJ; Lee MG
Res Commun Mol Pathol Pharmacol; 1997 Jun; 96(3):299-306. PubMed ID: 9261889
[TBL] [Abstract][Full Text] [Related]
15. Pharmacokinetic and tissue distribution changes of adriamycin and adriamycinol after intravenous administration of adriamycin to uranyl nitrate-induced acute renal failure rats.
Lee HJ; Paik WH; Lee MG
Res Commun Mol Pathol Pharmacol; 1996 Feb; 91(2):195-204. PubMed ID: 8832911
[TBL] [Abstract][Full Text] [Related]
16. [Comparative studies on the pharmacokinetics between THP and adriamycin in the same patients].
Nakajima O; Imamura Y; Matsumoto A; Koyama Y; Shomura T; Kawamura K; Murata S
Gan To Kagaku Ryoho; 1986 Feb; 13(2):261-70. PubMed ID: 3947106
[TBL] [Abstract][Full Text] [Related]
17. Determination of doxorubicin and metabolites in murine specimens by high-performance liquid chromatography.
van Asperen J; van Tellingen O; Beijnen JH
J Chromatogr B Biomed Sci Appl; 1998 Aug; 712(1-2):129-43. PubMed ID: 9698235
[TBL] [Abstract][Full Text] [Related]
18. Determination of adriamycin (doxorubicin) and related fluorescent compounds in rat lymph and gall by high-performance liquid chromatography.
Shinozawa S; Oda T
J Chromatogr; 1981 Aug; 212(3):323-30. PubMed ID: 7263801
[TBL] [Abstract][Full Text] [Related]
19. Determination of adriamycin, adriamycinol and their 7-deoxyaglycones in human serum by high-performance liquid chromatography.
Cummings J; Stuart JF; Calman KC
J Chromatogr; 1984 Nov; 311(1):125-33. PubMed ID: 6520153
[TBL] [Abstract][Full Text] [Related]
20. Disposition kinetics of adriamycin, adriamycinol and their 7-deoxyaglycones in AKR mice bearing a sub-cutaneously growing ridgway osteogenic sarcoma (ROS).
Cummings J; Merry S; Willmott N
Eur J Cancer Clin Oncol; 1986 Apr; 22(4):451-60. PubMed ID: 3460809
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
